Evaluation of beta thromboglobulin levels in cancer patients: effects of antitumor chemotherapy.
D000328:Adult; D000368:Aged; D001609:Beta-Globulins / Q000096:biosynthesis*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy; D010976:Platelet Count; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D001620:beta-Thromboglobulin / Q000096:biosynthesis*
D001609:Beta-Globulins; D001620:beta-Thromboglobulin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone